Valsartan/hydrochlorothiazide
From Infogalactic: the planetary knowledge core
| Combination of | |
|---|---|
| Valsartan | Angiotensin II receptor antagonist |
| Hydrochlorothiazide | Thiazide diuretic |
| Clinical data | |
| Trade names | co-vasotec |
| AHFS/Drugs.com | FDA Professional Drug Information |
| MedlinePlus | a611032 |
| Licence data | US FDA:link |
| Pregnancy category |
|
| Legal status |
|
| Routes of administration |
Oral |
| Identifiers | |
| ATC code | C09DA03 (WHO) |
| PubChem | CID: 9810581 |
| KEGG | D09197  |
| (verify) | |
Valsartan/hydrochlorothiazide (INNs, trade name Co-vasotec) is an antihypertensive drug combination of an angiotensin II receptor antagonist with hydrochlorothiazide,[1] the most common diuretic to be combined with other blood pressure lowering substances.
See also
References
- ↑ Drugs.com: Diovan HCT
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
Categories:
- Drugs that are a combination of chemicals
- Chemical articles without CAS Registry Number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without InChI source
- Articles without UNII source
- Angiotensin II receptor antagonists
- Combination drugs
- Novartis
- Cardiovascular system drug stubs
